Increased Plasma-Free Hemoglobin Levels Identify Hemolysis in Patients With Cardiogenic Shock and a Trans valvular Micro-Axial Flow Pump

Incidence of Hemolysis in Patients with Cardiogenic Shock Treated with Impella Percutaneous Left Ventricular Assist Device

(2016) Amit P. Badiye et al.   ASAIO JOURNAL

Shear-Induced Hemolysis: Species Differences

(2015) Jun Ding et al.   ARTIFICIAL ORGANS

Haemolysis as a first sign of thromboembolic event and acute pump thrombosis in patients with the continuous-flow left ventricular assist device HeartMate II

(2015) S. Akin et al.   Netherlands Heart Journal

National Trends in the Utilization of Short-Term Mechanical Circulatory Support

(2014) Robert Stretch et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Diagnosis of hemolysis and device thrombosis with lactate dehydrogenase during left ventricular assist device support

(2013) Palak Shah et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Hemolysis: A harbinger of adverse outcome after left ventricular assist device implant

(2013) Jennifer A. Cowger et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

The Current Use of Impella 2.5 in Acute Myocardial Infarction Complicated by Cardiogenic Shock: Results from the USpella Registry

(2013) WILLIAM W. O'NEILL et al.   JOURNAL OF INTERVENTIONAL CARDIOLOGY

Percutaneous Left-Ventricular Support With the Impella-2.5–Assist Device in Acute Cardiogenic Shock

(2012) Alexander Lauten et al.   Circulation-Heart Failure

A Prospective Feasibility Trial Investigating the Use of the Impella 2.5 System in Patients Undergoing High-Risk Percutaneous Coronary Intervention (The PROTECT I Trial)

(2009) Simon R. Dixon et al.   JACC-Cardiovascular Interventions